Gmika 500mg Injection
Marketer
Gat Pharmaceutical Private Limited
Salt Composition
Amikacin (500mg)
Overview Gmika 500mg Injection
Cefixime 500mg injection combats a broad spectrum of bacterial infections, including those affecting the urinary tract, musculoskeletal system, respiratory system (like pneumonia), central nervous system, and bloodstream. Prophylactically, it's also administered to hospitalized individuals to ward off infection. Its mechanism involves inhibiting bacterial proliferation. Administered intravenously or intramuscularly by a healthcare professional only, it requires adherence to a prescribed dosage schedule. Consistent, evenly spaced doses are crucial; premature discontinuation risks relapse or exacerbation. Minor side effects can include injection site irritation and elevated blood urea nitrogen. Persistent symptoms or lack of improvement necessitate medical consultation. High doses may rarely cause vertigo, nephrotoxicity, and ototoxicity. Close monitoring, including renal, auditory, and urinalysis, may be implemented. This medication is contraindicated during pregnancy; disclose pregnancy, pregnancy planning, or breastfeeding to your physician.
Primary Ingredients of Gmika 500mg Injection
No text provided to rephrase.
Uses of Gmika 500mg Injection
Infections caused by bacteria
Major Benefits of Gmika 500mg Injection:
Administering this medication will be done by your physician or their qualified nurse; self-medication is strictly prohibited.
Common Side effects of Gmika 500mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Gmika 500mg Injection:
Administering this medication will be handled by your healthcare provider; self-medication is strictly prohibited.
How Gmika 500mg Injection works:
The antibiotic injection, Gmika 500mg, inhibits bacterial proliferation by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of Gmika 500mg Injection and alcohol.
PregnancyCONSULT YOUR DOCTOR
Administering Gmika 500mg Injection during pregnancy is contraindicated due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might consider prescribing it if the potential benefits outweigh the inherent dangers. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Gmika, 500mg, poses no known breastfeeding risks. Research in humans indicates minimal drug transfer to breast milk, presenting no apparent danger to the infant.
DrivingUNSAFE
Administering a 500mg Gmika injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects manifest.
KidneyCAUTION
Caution is advised when administering Gmika 500mg Injection to individuals with impaired renal function. A modified dosage of Gmika 500mg Injection may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Gmika 500mg Injection appears to pose minimal risk for individuals with hepatic impairment. Preliminary findings indicate dose modification may be unnecessary; however, medical advice is strongly recommended.
What if you forget to take Gmika 500mg Injection :
Omit a Gmika 500mg Injection dose? Seek medical advice.
Facts to Know About Gmika 500mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action Class | Aminoglycoside antibiotics |
3,018 People bought this recently